Browse studies

Find your next paid study

27,333 recruiting studies available now

Efficacy and Safety of Leadless Pacemakers Versus Left Bundle Area Pacing - A Preliminary Exploration

This is a prospective, randomized controlled (1:1) multicenter trial. The pilot study will be conducted up to three clinical sites in the United States. The pr…

Pacemaker ImplantationAV Node Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCHNCT06690333

Phase 2

An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)

This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. It will also assess whe…

Depression

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Charles RaisonNCT06512194

Phase 4

Randomized Prospective Evaluation of Ovine Forestomach Matrix (OFM) and NPWT to Accelerate Tissue Coverage Over Exposed Structures

Demonstrate faster tissue coverage of exposed structures using OFM in combination with negative pressure wound therapy (NPWT), versus NPWT alone

Soft Tissue DefectsSoft Tissue WoundsTraumatic Soft Tissue Defect

Estimated

~$25 – $1,400

Actual pay is set by the research site.

Aroa Biosurgery LimitedNCT07385313

Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent…

Primary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT02026388

Phase 1

REPEAT: RE-irradiation With a Partial brEast, Accelerated Technique: A Single-Center, Multi-site, Prospective, Phase I/II Clinical Trial

This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local c…

Breast Cancer Recurrent

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Dartmouth-Hitchcock Medical CenterNCT07612254

A Multi-Modal Wearable Sensor for Early Detection of Cognitive Decline and Remote Monitoring of Cognitive-Motor Decline Over Time

This observational study will enroll approximately 100 participants evenly split by cognitive status (Cognitively Impaired vs Non-Cognitively Impaired), and in…

Mild Cognitive Impairment (MCI)Older Adults With Cognitive DeclineOlder Adults

Estimated

~$10 – $1,125

Actual pay is set by the research site.

BioSensicsNCT07780162

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Background: After an allogeneic hematopoietic stem cell transplant (HSCT), the donor genome is found in the recipient s circulation and tissues. Post-HSCT re…

LeukemiaLymphomaHematologic Malignancy

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06856226

Observational

Effectiveness and Safety of Virtual Reality for the Treatment of Functional Dyspepsia

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

Functional Dyspepsia

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT05836597

Phase 2

A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)

This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung can…

Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Estimated

~$75 – $3,000

Actual pay is set by the research site.

SWOG Cancer Research NetworkNCT06031688

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is parti…

Neoplasms, Connective and Soft TissueBone Neoplasms

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT02677961

Phase 1

Early Phase 1 Window of Opportunity Study of Oral DSP-0390 in Gliomas

This study focuses on determining the pharmacokinetic and pharmacodynamic effect of DSP-0390 in brain and blood from patients with IDH-mutant glioma undergoing…

Glioma, MalignantIDH Mutation

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Washington University School of MedicineNCT06636162

Phase 2

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures

Focal Onset SeizurePrimary Generalized Epilepsy

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Praxis Precision MedicinesNCT06908356